Intestinal Dysbiosis, Tight Junction Proteins, and Inflammation in Rheumatoid Arthritis Patients: A Cross-Sectional Study.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Aug 2024
Historique:
received: 05 07 2024
revised: 02 08 2024
accepted: 07 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Recent studies point to intestinal permeability as an important factor in the establishment and development of rheumatoid arthritis (RA). Tight junctions (TJs) play a major role in intestinal homeostasis. The alteration of this homeostasis is related to RA. Furthermore, RA patients present dysbiosis and a lower microbiota diversity compared to healthy individuals. A cross-sectional study including RA patients and sex- and age-matched healthy controls was performed. The quantification of TJ proteins was carried out by ELISA. Gut microbiota was evaluated by NGS platform Ion Torrent S. The inflammatory variables included were DAS28, CRP, inflammatory cytokines (IL-6, IL-1, TNF-α) and oxidised LDL. Claudin-1 levels showed significant differences between groups. Results evidenced a correlation between claudin-1 values and age (

Identifiants

pubmed: 39201334
pii: ijms25168649
doi: 10.3390/ijms25168649
pii:
doi:

Substances chimiques

Tight Junction Proteins 0
Claudin-1 0
zonulin 0
C-Reactive Protein 9007-41-4
Cytokines 0
Haptoglobins 0
Protein Precursors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : RD21/0002/0037
Organisme : Instituto de Salud Carlos III
ID : PI18/00824
Organisme : Instituto de Salud Carlos III
ID : PI22/01207
Organisme : Instituto de Salud Carlos III
ID : CP22/00096

Auteurs

Arkaitz Mucientes (A)

Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29010 Málaga, Spain.
UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.

José Manuel Lisbona-Montañez (JM)

Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29010 Málaga, Spain.
UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.
Departamento de Medicina y Dermatología, Universidad de Málaga, 29010 Málaga, Spain.

Natalia Mena-Vázquez (N)

Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29010 Málaga, Spain.
UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.

Patricia Ruiz-Limón (P)

Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29010 Málaga, Spain.
Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Málaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Sara Manrique-Arija (S)

Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29010 Málaga, Spain.
UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.
Departamento de Medicina y Dermatología, Universidad de Málaga, 29010 Málaga, Spain.

Aimara García-Studer (A)

Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29010 Málaga, Spain.
UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.
Departamento de Medicina y Dermatología, Universidad de Málaga, 29010 Málaga, Spain.

Fernando Ortiz-Márquez (F)

Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29010 Málaga, Spain.
UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.
Departamento de Medicina y Dermatología, Universidad de Málaga, 29010 Málaga, Spain.

Antonio Fernández-Nebro (A)

Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29010 Málaga, Spain.
UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.
Departamento de Medicina y Dermatología, Universidad de Málaga, 29010 Málaga, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH